Chronic HIV Infection
Chronic HIV infection is a long-term viral infection that attacks the immune system, making it harder for the body to fight off infections and diseases. It can lead to serious health issues if not managed properly.
HIV Treatment: IMC-M113V Study
We are evaluating a new treatment, IMC-M113V, for people with chronic HIV infection who are already on medication. The study will help us understand its safety and how it affects the immune system.
3-6 monthsSafety phase (I)Efficacy phase (II)No PlaceboCost ReimbursementInvestigational MedicinesInjectionInfectious DiseasesInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 65 years old?
- Do you have HIV and have you been on treatment for at least 12 months?
- Are you currently weighing at least 50 kg (110 lbs)?
- Are you pregnant or breastfeeding?
- Are you taking any medications that suppress your immune system, like steroids?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Imc-M113V
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Brussel
Infectious Diseases
Ganshoren, Belgium
Universitair Ziekenhuis Gent
Infectious Diseases
Ledeberg, Belgium
Hospital Germans Trias I Pujol
Infectious Disease
Badalona, Spain
Sponsor: Immunocore Limited
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.